Stephen B Shrewsbury Impel Pharmaceuticals Inc (IMPL) insider trading activity

IMPL Quotes by TradingView

Stephen B Shrewsbury is Chief Medical Officer of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 97,990 shares of IMPL, which is worth approximately $1,959. The most recent transaction as insider was on Mar 29, 2022, when has been sold 24,606 shares (Common Stock) at a price of $1.97 per share, resulting in proceeds of $48,474. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98K
0% 3M change
0% 12M change
Total Value Held $1,959

STEPHEN B SHREWSBURY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2022
BUY
Exercise of conversion of derivative security
$48,474 $1.97 p/Share
24,606 Added 20.07%
97,990 Common Stock
Sep 21 2021
BUY
Exercise of conversion of derivative security
$180,525 $2.46 p/Share
73,384 Added 50.0%
73,384 Common Stock
SBS

Stephen B Shrewsbury

Chief Medical Officer
Seattle, WA

Track Institutional and Insider Activities on IMPL

Follow IMPEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMPL shares.

Notify only if

Insider Trading

Get notified when an Impel Pharmaceuticals Inc insider buys or sells IMPL shares.

Notify only if

News

Receive news related to IMPEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMPL